Adaptimmune therapeutics’ chief medical officer sells $3,243 in inventory By Investing.com
In a current transaction, Norry Elliot, the Chief Medical (TASE:) Officer of Adaptimmune Therapeutics PLC (NASDAQ:), ...
Read moreIn a current transaction, Norry Elliot, the Chief Medical (TASE:) Officer of Adaptimmune Therapeutics PLC (NASDAQ:), ...
Read more Copyright © 2022 - Newshare 24.
Newshare 24 is not responsible for the content of external sites.